Effects of resistance exercise and whey protein intake in the treatment of sarcopenia
Not Applicable
- Conditions
- sarcopenia
- Registration Number
- JPRN-UMIN000043794
- Lead Sponsor
- Tokushima University
- Brief Summary
Compared to baseline, ASMI and HGS increased significantly at the end of the intervention period in the RT+PRO group; however, there were no significant differences in change of ASMI and change of HGS between each group. At 24 weeks of the de-training period, change of ASMI and change of HGS were higher in the RT + PRO group than in the RT group.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 81
Inclusion Criteria
Not provided
Exclusion Criteria
Nutritional therapies for conditions such as type 2 diabetes and chronic kidney disease. Severe dementia, dysphagia, and joint disorders. Resistance training has been conducted twice a week for the past year. Non-sarcopenia.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Change of skeletal muscle mass index. Baseline, end of intervention, at 12 weeks of de-training, at 24 weeks of de-training
- Secondary Outcome Measures
Name Time Method remission of sarcopenia. Change of grip strength, knee extension strength, gait speed. Baseline, end of intervention, at 12 weeks of de-training, at 24 weeks of de-training